Cargando…
Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
Autores principales: | De Kort, Anna M., Kuiperij, H. Bea, Alcolea, Daniel, Kersten, Iris, Versleijen, Alexandra A. M., Greenberg, Steven M., Stoops, Erik, Schreuder, Floris H. B. M., Klijn, Catharina J. M., Lleó, Alberto, Claassen, Jurgen A. H. R., Verbeek, Marcel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597269/ https://www.ncbi.nlm.nih.gov/pubmed/34784952 http://dx.doi.org/10.1186/s13195-021-00929-x |
Ejemplares similares
-
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: De Kort, Anna M., et al.
Publicado: (2021) -
Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease
por: De Kort, Anna M., et al.
Publicado: (2021) -
Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy
por: Vervuurt, Marc, et al.
Publicado: (2023) -
Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: van den Berg, Emma, et al.
Publicado: (2023) -
Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis
por: Jäkel, Lieke, et al.
Publicado: (2021)